Apogee Therapeutics Statistics
Total Valuation
APGE has a market cap or net worth of $6.23 billion. The enterprise value is $5.33 billion.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, before market open.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APGE has 73.85 million shares outstanding. The number of shares has increased by 9.96% in one year.
| Current Share Class | 60.36M |
| Shares Outstanding | 73.85M |
| Shares Change (YoY) | +9.96% |
| Shares Change (QoQ) | +14.61% |
| Owned by Insiders (%) | 2.04% |
| Owned by Institutions (%) | 85.80% |
| Float | 56.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.38 |
| P/TBV Ratio | 6.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.57, with a Debt / Equity ratio of 0.01.
| Current Ratio | 26.57 |
| Quick Ratio | 26.38 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.57% and return on invested capital (ROIC) is -21.75%.
| Return on Equity (ROE) | -31.57% |
| Return on Assets (ROA) | -21.11% |
| Return on Invested Capital (ROIC) | -21.75% |
| Return on Capital Employed (ROCE) | -31.41% |
| Weighted Average Cost of Capital (WACC) | 9.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$980,241 |
| Employee Count | 261 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, APGE has paid $278,000 in taxes.
| Income Tax | 278,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +136.84% in the last 52 weeks. The beta is 1.02, so APGE's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +136.84% |
| 50-Day Moving Average | 71.36 |
| 200-Day Moving Average | 57.28 |
| Relative Strength Index (RSI) | 64.97 |
| Average Volume (20 Days) | 1,278,730 |
Short Selling Information
The latest short interest is 8.80 million, so 11.91% of the outstanding shares have been sold short.
| Short Interest | 8.80M |
| Short Previous Month | 8.62M |
| Short % of Shares Out | 11.91% |
| Short % of Float | 15.49% |
| Short Ratio (days to cover) | 10.92 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -285.60M |
| Pretax Income | -255.57M |
| Net Income | -255.84M |
| EBITDA | -284.18M |
| EBIT | -285.60M |
| Earnings Per Share (EPS) | -$4.22 |
Full Income StatementBalance Sheet
The company has $730.19 million in cash and $8.85 million in debt, with a net cash position of $894.07 million or $12.11 per share.
| Cash & Cash Equivalents | 730.19M |
| Total Debt | 8.85M |
| Net Cash | 894.07M |
| Net Cash Per Share | $12.11 |
| Equity (Book Value) | 903.88M |
| Book Value Per Share | 13.21 |
| Working Capital | 713.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$227.45 million and capital expenditures -$5.15 million, giving a free cash flow of -$232.60 million.
| Operating Cash Flow | -227.45M |
| Capital Expenditures | -5.15M |
| Depreciation & Amortization | 1.42M |
| Net Borrowing | n/a |
| Free Cash Flow | -232.60M |
| FCF Per Share | -$3.15 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.96% |
| Shareholder Yield | -9.96% |
| Earnings Yield | -4.11% |
| FCF Yield | -3.73% |
Analyst Forecast
The average price target for APGE is $109.67, which is 30.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $109.67 |
| Price Target Difference | 30.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -10.68% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
